Quantcast
Home > Quotes > XTLB
XTLB

XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB) Quote & Summary Data

$2.6
*  
0.11
4.06%
Get XTLB Alerts
*Delayed - data as of Nov. 16, 2018  -  Find a broker to begin trading XTLB now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
Today's High / Low
$ 2.93 / $ 2.60
Share Volume
958
50 Day Avg. Daily Volume
20,697
Previous Close
$ 2.71
52 Week High / Low
$ 3.9399 / $ 1.5501
Market Cap
13,369,348
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.65

Intraday Chart

Shares Traded

Share Volume:
958
50 Day Avg. Daily Volume:
20,697

Trading Range

The current last sale of $2.60 is 67.73% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 2.93 $ 3.9399
 Low: $ 2.60 $ 1.5501

Company Description (as filed with the SEC)

We are a biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Our current drug development program is focused on the development of hCDR1 for the treatment of SLE and SS. Company Information and History Our legal and commercial name is XTL Biopharmaceuticals Ltd. We were established as a private company limited by shares under the laws of the State of Israel on March 9, 1993, under the name Xenograft Technologies Ltd. We re-registered as a public company on June 7, 1993, in Israel, and changed our name to XTL Biopharmaceuticals Ltd. on July 3, 1995. We commenced operations to use and commercialize technology developed at the Weizmann Institute, in Rehovot, Israel.

Nasdaq Official Price

Open Price:
$ 2.79
Open Date:
Nov. 16, 2018
Close Price:
$ 2.71
Close Date:
Nov. 16, 2018

Research Brokers before you trade

Want to trade FX?

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x